Biotech

All Articles

Novo inks $600M NanoVation bargain to analyze hereditary drugs ex-liver

.Novo Nordisk is continuing its push into genetic medications, agreeing to compensate NanoVation The...

Innovent links cytokine to colon cancer cells reactions

.Innovent Biologics has made the instance that its checkpoint inhibitor-cytokine combination healthy...

Merck, Daiichi ADC reaches target in period 3 lung cancer cells study

.A period 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugat...

Rakovina strengthens AI concentrate with collab to choose cancer targets

.Five months after Rakovina Therapeutics rotated towards expert system, the cancer-focused biotech h...

Ascendis' dwarfism medication hits in stage 3, endangers BioMarin

.Ascendis Pharma has actually become a possible hazard to BioMarin's Voxzogo, reporting period 3 dev...

Despite ph. 3 miss out on, Alkeus views path ahead of time for eye ailment resource

.Though Alkeus Pharmaceuticals' dental eye ailment asset fell short to considerably decrease geograp...

Kairos goes social with $6M IPO to fund trials of cancer drug

.With a trio of biotechs reaching the Nasdaq on Friday, it was actually very easy to miss a smaller-...

Vaccine and Keytruda combination efficient in squamous tissue cancer

.Immune gate preventions are the superheroes of cancer cells therapy. Drugs like Bristol Myers Squib...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings ...

Regeneron's Opdualag competitor presents 57% action fee

.Regeneron is back with lasting follow-up for its LAG-3 inhibitor and also PD-1 prevention combinati...